Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy Universal Biosensors shares
Own Universal Biosensors shares in just a few minutes.
Updated
Fact checked
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Universal Biosensors, Inc is a medical devices business based in Australia. Universal Biosensors shares (UBI) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Universal Biosensors has a trailing 12-month revenue of around $4 million..
How to buy shares in Universal Biosensors
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Universal Biosensors. Find the share by name or ticker symbol: UBI. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Universal Biosensors reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.32, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Universal Biosensors. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
🧪How we chose these brokers
For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.What's in this guide?
- Universal Biosensors key stats
- Compare share trading platforms
- Is Universal Biosensors stock a buy or sell?
- Universal Biosensors performance over time
- Are Universal Biosensors shares over-valued?
- Universal Biosensors's financials
- How volatile are Universal Biosensors shares?
- Does Universal Biosensors pay a dividend?
- Other common questions
How has coronavirus impacted Universal Biosensors's share price?
Since the stock market crash in March caused by coronavirus, Universal Biosensors's share price has had significant positive movement.
Its last market close was $0.32, which is 45.31% up on its pre-crash value of $0.175 and 146.15% up on the lowest point reached during the March crash when the shares fell as low as $0.13.
If you had bought $1,000 worth of Universal Biosensors shares at the start of February 2020, those shares would have been worth $777.78 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,777.78.
Universal Biosensors share price
Use our graph to track the performance of UBI stocks over time.Universal Biosensors shares at a glance
Information last updated 2020-10-20.
| 52-week range | $0.13 - $0.345 |
|---|---|
| 50-day moving average | $0.3084 |
| 200-day moving average | $0.2457 |
| Target price | $0.51 |
| PE ratio | 0.9635 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.192 |
Share Trading Account Offer
IG Share Trading Offer
AUD 8
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
More info
Important: Share trading carries risk of capital loss.
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Universal Biosensors stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Universal Biosensors price performance over time
Historical closes compared with the close of A$0.32 on 2020-10-22
| 1 week (2021-01-12) | -43.86% |
|---|---|
| 1 month (2020-12-18) | -20.00% |
| 3 months (2020-10-19) | -1.54% |
| 6 months (2020-07-17) | 45.45% |
| 1 year (2020-01-17) | 82.86% |
|---|---|
| 2 years (2019-01-18) | 45.45% |
| 3 years (2018-01-19) | 18.52% |
| 5 years (2016-01-19) | -28.89% |
Is Universal Biosensors under- or over-valued?
Valuing Universal Biosensors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Biosensors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Biosensors's P/E ratio
Universal Biosensors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Universal Biosensors shares trade at around 1x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Universal Biosensors's EBITDA
Universal Biosensors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.9 million (£0.0 million).
The EBITDA is a measure of a Universal Biosensors's overall financial performance and is widely used to measure a its profitability.
Universal Biosensors financials
| Revenue TTM | $4 million |
|---|---|
| Gross profit TTM | $3.3 million |
| Return on assets TTM | -12.18% |
| Return on equity TTM | -13.38% |
| Profit margin | -147.35% |
| Book value | 0.231 |
| Market capitalisation | $55 million |
TTM: trailing 12 months
Universal Biosensors share dividends
We're not expecting Universal Biosensors to pay a dividend over the next 12 months.
Universal Biosensors share price volatility
Over the last 12 months, Universal Biosensors's shares have ranged in value from as little as $0.13 up to $0.345. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Universal Biosensors's is 0.6151. This would suggest that Universal Biosensors's shares are less volatile than average (for this exchange).
Universal Biosensors overview
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, designs and develops electrochemical cells in Australia. The company focuses on the research, development, and manufacture of medical or testing devices. It uses electrochemical cell technology platform to develop point of use devices for various industries, including healthcare, food and drink, and agriculture. The company offers prothrombin time international normalized ratio coagulation test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. It also owns, operates, and manages a hemostasis laboratory. The company was founded in 2001 and is based in Rowville, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Universal Biosensors units | A$51.73
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
-
How to buy Universal Biosensors units | A$52.92
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
-
How to buy Universal Biosensors units | A$103.5
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
-
How to buy Universal Biosensors units | A$23.84
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
-
How to buy Universal Biosensors units | A$88.09
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
-
How to buy Universal Biosensors units | A$16.16
Steps to owning and managing ETFS FANG+ ETF units.
-
How to buy Universal Biosensors units | A$75.2
Steps to owning and managing ETFS S&P Biotech ETF units.
-
How to buy Universal Biosensors units | A$50.77
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
-
How to buy Universal Biosensors units | A$9.4
Steps to owning and managing BetaShares India Quality ETF units.
Ask an Expert
